Milae Bioresources Co. Ltd Net Assets
Milae Bioresources Co. Ltd net assets. Based on the latest financial reports, Milae Bioresources Co. Ltd (218150) has net assets worth ₩39.98 Billion KRW (≈ $27.10 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩62.08 Billion ≈ $42.07 Million USD) and total liabilities (₩22.10 Billion ≈ $14.97 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 218150 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩39.98 Billion |
| % of Total Assets | 64.41% |
| Annual Growth Rate | 22.18% |
| 5-Year Change | 30.01% |
| 10-Year Change | N/A |
| Growth Volatility | 76.61 |
Net Assets of Milae Bioresources Co. Ltd (2016–2025)
Net assets of Milae Bioresources Co. Ltd from 2016 to 2025. This chart illustrates how Milae Bioresources Co. Ltd's net assets have evolved over time, based on quarterly financial data. See Milae Bioresources Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.
Annual Net Assets for Milae Bioresources Co. Ltd (2016–2025)
The table below shows the annual net assets of Milae Bioresources Co. Ltd from 2016 to 2025. For live market cap and overall valuation, see how much is Milae Bioresources Co. Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩42.75 Billion ≈ $28.97 Million |
-1.91% |
| 2024-12-31 | ₩43.59 Billion ≈ $29.54 Million |
-1.30% |
| 2023-12-31 | ₩44.16 Billion ≈ $29.93 Million |
+8.38% |
| 2022-12-31 | ₩40.75 Billion ≈ $27.61 Million |
+23.90% |
| 2021-12-31 | ₩32.89 Billion ≈ $22.29 Million |
+8.00% |
| 2020-12-31 | ₩30.45 Billion ≈ $20.64 Million |
+2.66% |
| 2019-12-31 | ₩29.66 Billion ≈ $20.10 Million |
+4.36% |
| 2018-12-31 | ₩28.42 Billion ≈ $19.26 Million |
+15.24% |
| 2017-12-31 | ₩24.66 Billion ≈ $16.71 Million |
+249.97% |
| 2016-12-31 | ₩7.05 Billion ≈ $4.78 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Milae Bioresources Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 22647.1% over the analyzed period, indicating profitable operations and earnings retention.
Milae Bioresources Co. Ltd Net Assets Breakdown (December 2025)
Milae Bioresources Co. Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩17.46 Billion | 43.23% |
| Other Components | ₩22.93 Billion | 56.77% |
| Total Equity | ₩40.39 Billion | 100.00% |
Milae Bioresources Co. Ltd Competitors by Market Cap
The table below lists competitors of Milae Bioresources Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Golden Heaven Group Holdings Ltd. Ordinary Shares
NASDAQ:GDHG
|
$22.36 Million |
|
Key Tronic Corporation
NASDAQ:KTCC
|
$22.37 Million |
|
DL Holdings Co Ltd Preferred
KO:000215
|
$22.38 Million |
|
M4B SA ZY 8
F:24D
|
$22.38 Million |
|
Ratio Energies LP
TA:RATI-L
|
$22.34 Million |
|
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904
|
$22.34 Million |
|
Verena Multi Finance Tbk
JK:VRNA
|
$22.33 Million |
|
Sungwoo Electronics Co. Ltd
KQ:081580
|
$22.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Milae Bioresources Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 43,585,458,300 to 40,387,170,830, a change of -3,198,287,470 (-7.3%).
- Net loss of 3,259,459,290 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-3.26 Billion | -8.07% |
| Other Changes | ₩61.17 Million | +0.15% |
| Total Change | ₩- | -7.34% |
Book Value vs Market Value Analysis
This analysis compares Milae Bioresources Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.82x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1996.43 | ₩1692.00 | x |
| 2017-12-31 | ₩1538.62 | ₩1692.00 | x |
| 2018-12-31 | ₩1597.99 | ₩1692.00 | x |
| 2019-12-31 | ₩1667.62 | ₩1692.00 | x |
| 2020-12-31 | ₩1720.97 | ₩1692.00 | x |
| 2021-12-31 | ₩1854.08 | ₩1692.00 | x |
| 2022-12-31 | ₩2147.25 | ₩1692.00 | x |
| 2023-12-31 | ₩2264.77 | ₩1692.00 | x |
| 2024-12-31 | ₩2235.66 | ₩1692.00 | x |
| 2025-12-31 | ₩2071.61 | ₩1692.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Milae Bioresources Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.82%
- • Asset Turnover: 1.15x
- • Equity Multiplier: 1.46x
- Recent ROE (-8.07%) is below the historical average (0.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.84% | 0.00% | 0.00x | 1.22x | ₩-645.25 Million |
| 2017 | -8.11% | -4.89% | 1.32x | 1.26x | ₩-4.47 Billion |
| 2018 | 6.25% | 5.05% | 1.03x | 1.20x | ₩-1.07 Billion |
| 2019 | 3.47% | 2.06% | 1.30x | 1.30x | ₩-1.94 Billion |
| 2020 | 3.13% | 2.01% | 1.22x | 1.28x | ₩-2.09 Billion |
| 2021 | 3.09% | 1.52% | 1.20x | 1.68x | ₩-2.27 Billion |
| 2022 | 2.36% | 1.27% | 1.35x | 1.38x | ₩-3.11 Billion |
| 2023 | 1.00% | 0.74% | 1.16x | 1.17x | ₩-3.97 Billion |
| 2024 | -0.99% | -0.69% | 0.98x | 1.47x | ₩-4.79 Billion |
| 2025 | -8.07% | -4.82% | 1.15x | 1.46x | ₩-7.30 Billion |
Industry Comparison
This section compares Milae Bioresources Co. Ltd's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $210,360,706,578
- Average return on equity (ROE) among peers: 12.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Milae Bioresources Co. Ltd (218150) | ₩39.98 Billion | 0.84% | 0.55x | $22.35 Million |
| Hantop Inc (002680) | $51.63 Billion | 6.45% | 1.98x | $62.01 Million |
| Woorison F&G Co. Ltd (073560) | $180.12 Billion | 15.04% | 0.98x | $69.16 Million |
| Sunjin (136490) | $582.07 Billion | 20.43% | 1.34x | $162.44 Million |
| Korea Mcnulty Co Ltd (222980) | $27.62 Billion | 9.94% | 0.37x | $12.46 Million |
About Milae Bioresources Co. Ltd
Milae Bioresources Co., Ltd. provides feed additives in Korea. It also offers processed feed, feed preservatives, and feed ingredients. In addition, the company offers minerals and other specialty feed additives. The company was founded in 1998 and is based in Seoul, South Korea.